Senior insider sale
VP, Corp Controller and CAO at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$353.6K
5.38K shares
What this filing means
CALVIN SANDRA plans to sell 5.38K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $353.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/15/2026ACC: 0001950047-26-009523
Officer· VP, Corp Controller and CAO
Since Sep 2021
5.38K
Shares to sell
$353.6K
Approx. market value
5.38K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/15/2026
5.38KTotal acquired5.38K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/15/2026 | Exercise of Stock Options Cash | 5.38K | — |
| Total | 5.38K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5.38K
Market value
$353.6K
9/15/2026
Total
Units
5.38K
Value
$353.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/15/2026 | 5.38K | $353.6K | NASDAQ | Planned |
| Total | 5.38K | $353.6K | ||